Epicutaneous Testing of Cosmetics for Skin Compatibility
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Patch test application.
- Who it may be relevant to
- Registry conditions: Dermatitis. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Switzerland
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Epicutaneous Testing of Cosmetic Products to Determine Skin Compatibility
Overview
The dermatological testing of cosmetic products which are new on the market, or existing products with novel formulations is common and a useful procedure, yet necessary to alleviate common irritants and contact allergic reactions. Cosmetic products contain a range of substances that may be considered as potential irritants or contact allergens. In order to estimate that risk, cosmetics are tested by applying patch tests.
Detailed description
The dermatological testing of cosmetic products which are new on the market, or existing products with novel formulations is common and a useful procedure, yet necessary to alleviate common irritants and contact allergic reactions. Cosmetic products contain a range of substances that may be considered as potential irritants or contact allergens. In order to estimate that risk, cosmetics are tested by applying patch tests, as with allergic reactions.
Interventions
- Other Patch test application
test patch with cosmetic product will be applied to the back
Primary outcome measures
- Number of patients with positive patch test reactions to cosmetics [Time frame: 4 weeks]
Eligibility criteria
Inclusion criteria
- Men and women older than 18 years old
- Persons undergoing a diagnostic patch test for reason of a skin disease
- Signed written informed consent
Exclusion criteria
- Acute skin inflammation and eczema on the back
- Systemic corticosteroid and immunosuppressive therapy as well as UV exposure of the back within the last 4 weeks
- Topical corticosteroids used on the back within the last two weeks
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Other
Study locations
Switzerland · 1 center
- Inselspital Bern — Bern
Identifiers
NCT: NCT03024671 · KEK-BE 2016-01686